ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Esmya 5 mg tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5 mg of…
1. VIRUS DE L’HEPATITE B ET TRANSPLANTATION HEPATIQUEProfesseur Didier SAMUELCentre Hépatobiliaire Unité de Recherche Inserm-Paris Sud 785 Hopital Paul Brousse Villejuif,…
1. Dialysis made portable. Maria Gartner, Dimitar Genov, Stefan Silberfeld, Nico Strobl University of Applied Arts Vienna / ID2 Studio Esslinger / WS 2010 2. Dialysis made…
Slide 1Brachytherapy: The precise answer for tackling prostate cancer Prostate key messages Slide 2 FOR INTERNAL USE ONLY _ DO NOT DISTRIBUTE Prostate brachytherapy: Core…
Slide 1Highlights in the Management of Breast Cancer Rome, May 25-26, 2007 CLINICAL CASE Dott.ssa Jamara Giampietro Cattedra di Oncologia Medica Università G. DAnnunzio…
Slide 111 March 2009 Phase III Sativex ® MS Spasticity Trial Study GWSP0604 Preliminary Results Slide 2 2 Study Rationale: Route to Regulatory Approval In previous regulatory…
Slide 1New approaches in TB diagnosis and treatment Prof. M.A. Tageldin Slide 2 Slide 3 Slide 4 Slide 5 Slide 6 Slide 7 Slide 8 Why We Need New Tools to Fight TB New tools…
Slide 1Collective Planning of Cancer Care by Seza Orcun 09/18/2007 RCHE Fall Conference @ Purdue University Slide 2 Motivation Initiated by a clinical problem –How can…
1. Jurgen De Baerdemaeker – Director [email protected] IM ASSOCIATES Added value of Patient flow enabled forecasting in healthcare 2. Why IM Associates?…